San Francisco, CA, United States of America

Lance Berman

USPTO Granted Patents = 4 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2016-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Lance Berman: Innovator in Hypertension and Kidney Disease Treatment

Introduction

Lance Berman is a notable inventor based in San Francisco, CA, who has made significant contributions to the field of medical treatments for hypertension and kidney diseases. With a total of 4 patents to his name, Berman's work focuses on innovative methods to improve patient outcomes in managing these conditions.

Latest Patents

Berman's latest patents include groundbreaking inventions such as potassium-binding agents for treating hypertension and hyperkalemia. This invention relates to methods of treating hypertension in patients who may also suffer from chronic kidney disease or Type II diabetes mellitus. The methods involve administering an effective amount of a potassium-binding agent to lower blood pressure and stabilize kidney function. Another significant patent is for potassium-binding polymers, which similarly aim to treat hypertension and hyperkalemia in patients with related health issues.

Career Highlights

Throughout his career, Lance Berman has worked with reputable companies, including Vifor Ltd. and Relypsa, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to treating hypertension and kidney diseases.

Collaborations

Berman has collaborated with various professionals in the field, including his coworker Gerrit Klaerner, to advance research and development in his area of expertise.

Conclusion

Lance Berman's contributions to medical innovation, particularly in the treatment of hypertension and kidney diseases, highlight his role as a significant inventor in the healthcare industry. His patents reflect a commitment to improving patient care and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…